Advances in Immunopharmacology. Proceedings of the First International Conference on Immunopharmacology, July 1980, Brighton, England

Content: 
Related publications of interest, Page ii
Front Matter, Page iii
Copyright, Page iv
Immuno-enhancement and Drug Elimination Kinetics In Vivo, Pages 3-9, P.W. MULLEN
Immunostimulants and Hepatic Drug Metabolism, Pages 11-15, L.F. SOYKA
Effects of Interferon Inducers and Viral Infection on the Metabolism of Drugs, Pages 17-24, K.W. RENTON
The Pharmacologic Properties of Various Forms of Interferon, Pages 25-28, W.E. STEWART II, D.F. HANLEY, K.C. NASON, M. WIRANOWSKA-STEWART
The Pharmacokinetics of Immunoregulating Drugs: Immunopharmacokinetics, Pages 29-36, L.Z. BENET, B.M. FREY, T.L. DING, F.J. FREY
Assessment of Immunotoxicity Induced by the Environmental Chemicals 2,3,7,8-Tetrachlorodibenzo-p-dioxin, Diethylstilbestrol and Benzo(a)pyrene, Pages 37-50, J.H. DEAN, M.I. LUSTER, G.A. BOORMAN, K. CHAE, L.D. LAUER, R.W. LUEBKE, L.D. LAWSON, R.E. WILSON
On the Heterogeneity of Immunotherapeutic Agents, Pages 51-63, F. SPREAFICO, A. VECCHI, G. CONTI, M. SIRONI
A Multifaceted Role for Thymosin and its Composite Peptides in T-Cell Regulation, Pages 67-75, T.L.K. LOW, G.B. THURMAN, M.M. ZATZ, S.-K. HU, A.L. GOLDSTEIN
The Effect of the Serum Thymic Factor (FTS) on Suppressor T Cells, Pages 77-81, J.-F. BACH, M.-A. BACH, J. CHARREIRE, M. DARDENNE, D. ERARD, D. RIVEAU-KAISERLIAN
The Influence of Thymic Humoral Factor on Immunoproliferative Disorders and Viral Infections in Humans, Pages 83-88, Z.T. HANDZEL, R. ZAIZOV, I. VARSANO, S. LEVIN, M. PECHT, N. TRAININ
Virus Induced Immunomodulation, Pages 91-100, H. FRIEDMAN, S. SPECTER
Immunopharmacologic Approaches to Bacterial Infection, Pages 101-107, L. CHEDID, M. PARANT, F. PARANT
Immunopotentiation in Experimental Viral Infections, Pages 109-114, G.W. FISCHER
Immunologic Therapy of Viral Infections, Pages 115-125, L.N. SIMON, K. MAXWELL, T. GINSBERG, A.J. GLASKY
Effects of Sex Hormones on Spontaneous Autoimmune Disease in NZB/NZW Hybrid Mice, Pages 127-137, N. TALAL, J.R. ROUBINIAN, M.J. DAUPHINÉE, L.A. JONES, P.K. SIITERI
Immunopharmacologic Therapy of Connective Tissue Diseases, Pages 139-147, E.M. VEYS, J. SYMOENS
Immunopharmacologic Therapy of Immunodeficiency, Pages 149-156, L.E. SPITLER
Early Biochemical Responses of the Neutrophil to Chemoattractants, Pages 159-165, E.L. BECKER, H.J. SHOWELL, P.H. NACCACHE, R.I. SHA'AFI
Complement-derived Chemotactic Factors, Pages 167-174, D.E. CHENOWETH
Modification of Rat Polymorphonuclear Chemotaxis by Five Immunomodulators, Pages 175-181, J.P. GIROUD, M. ROCH-ARVEILLER
Use of Visual Analysis to Distinguish the Level of Action of Drugs on Neutrophil Chemotaxis and Locomotion, Pages 183-187, P.C. WILKINSON, R.B. ALLAN, A.C. WALKER
Receptors and Transductional Events in Leukocyte Chemotaxis, Pages 189-196, R. SNYDERMAN, M.C. PIKE
Mechanisms of Degranulation, Pages 197-205, S.T. HOFFSTEIN, H.M. KORCHAK, J.E. SMOLEN
Oxygen-dependent Cytotoxic Activity of Phagocytes, Pages 207-214, S.J. KLEBANOFF
Immunological and Tumor Responses to Various Immunotherapeutic Agents, Pages 217-225, M. CHIRIGOS, V. PAPADEMETRIOU, A. BARTOCCI, E. READ
Current Status of Human Cancer Immunotherapy, Pages 227-234, E.M. HERSH, J. GUTTERMAN, G. MAVLIGIT, S. MURPHY
Specific Active Immunization Against Cell Surface Antigens of Human Malignant Melanoma: Development of an Approach, Pages 235-242, H.F. OETTGEN, P. LIVINGSTON, T. TAKAHASHI, H. SHIKU, T. WATANABE, H. TAKEYAMA, A. HOUGHTON, A. ALBINO, L. RESNICK, K. LLOYD, L.J. OLD
Non-specific Inflammation and Host Resistance Against Pathogens, Pages 245-248, R.M. FAUVE, M.B. HEVIN, E. FONTAN
Influence of an Acute Non-immunological Inflammation on Resistance to Infection and Neoplasia, Pages 249-257, J.P. GIROUD, I. FLORENTIN, M. PELLETIER, D. NOLIBÉ
Immunopharmacology of Graft Rejection, Pages 259-266, G.P. LEWIS, T.-P. FAN
Autacoids as Modulators of the Immune Process: A Possible Therapeutic Strategy, Pages 267-275, K.L. MELMON
Immunopharmacologic Approaches to the Treatment of Allergy, Pages 277-284, F.-T. LIU, D.H. KATZ
Resistance Models for the Testing of Immunopotentiating Agents, Pages 287-294, G.H. WERNER, F. FLOC'H
The Assessment of the Immunotoxicity of Xenobiotics Experience with Tetrachlorodibenzodioxin and Saccharin, Pages 295-310, F. SPREAFICO, A. VECCHI, A. MANTOVANI, A. TAGLIABUE, M. SIRONI, W. LUINI, S. GARATTINI
Attempt at Functional Classification of Chemically-Defined Immunomodulators, Pages 311-325, I. FLORENTIN, M. BRULEY-ROSSET, J. SCHULZ, M. DAVIGNY, N. KIGER, G. MATHÉ
The Immunopharmacology of Immunotherapy: an Update, Pages 327-340, J.W. HADDEN
Modulation of the PMN Leukocyte Component of Hypersensitivity Reactions by Lipoxygenase Products of Arachidonic Acid, Pages 343-353, E.J. GOETZL, C.K. DERIAN, C.J. OWENS, F.H. VALONE
Arachidonic Acid and Related Fatty Acids in Leukocyte Modulation, Pages 355-356, C.W. PARKER
Generation of PGD2 and Release of Granule-associated Mediators by Mast Cells, Pages 357-364, R.A. LEWIS, S.T. HOLGATE, C.M. WINSLOW, K.F. AUSTEN
Arachidonate and Metabolites in Mitogen Activation of Lymphocyte Guanylate Cyclase, Pages 365-373, R.G. COFFEY, J.W. HADDEN
Prostaglandins and Macrophage Suppression, Pages 375-382, J.L. HUMES, F.A. KUEHL JR., P. DAVIES, R.J. BONNEY
Prostaglandins in Lymphocyte Suppressor Mechanisms, Pages 383-388, D.R. WEBB, K.J. WIEDER, I. NOWOWIEJSKI
Immunopharmacologic Approaches to Delineation of the Mechanism of Cell-Mediated Cytotoxicity Using Cytotoxic T Cell Clones, Pages 391-395, C.S. HENNEY, K. KURIBAYASHI, S. GILLIS, M. PLAUT, M. PALLADINO
Mechanism of Action of Soluble Immune Response Suppressor (SIRS), Pages 397-404, C.W. PIERCE, T.M. AUNE
The Diagnostic and Therapeutic Uses of Monoclonal Antibodies, Pages 405-409, G. JANOSSY
New Approaches to the Therapy of Allergic Diseases, Pages 411-418, M.K. BACH, H.G. JOHNSON, G.J. WHITE
Lymphocyte Activating Property of Human Leukocytic Pyrogen, Pages 419-425, C.A. DINARELLO, L.J. ROSENWASSER
The Central Nervous System and Immune Responses: Conditioned Immunopharmacologic Effects, Pages 427-434, R. ADER
Immunopharmacology of Schistosomiasis, Pages 435-440, K.S. WARREN
Mycobacteria, C. Parvum and Related Substances, Pages 443-446, Y. YAMAMURA, E. HERSH
Interferon Inducers, Pages 447-450, C. CHANY, A. JOHNSON
Immunopotentiators I, Pages 451-455, W. AMERY, G. RENOUX
Immunopotentiators II Isoprinosine, NPT 15392 and Azimexone: Modulators of Lymphocyte and Macrophage Development and Function, Pages 457-468, J.W. HADDEN, J. WYBRAN
Interferon, Pages 469-476, D.A.J. TYRRELL, M. KRIM
Polysaccharides and Related Substances I, Pages 477-484, N.R. DI LUZIO, G. CHIHARA
Polysaccharides and Related Substances II, Pages 485-490, M. CHIRIGOS, P. JACQUES
New Immunosuppressive Agents and Approaches, Pages 491-494, F. SPREAFICO, J.F. BOREL
New Host Modifying Drugs, Pages 495-497, H. FRIEDMAN, E.S.K. ASSEM
Muramyl Dipeptide Immunoadjuvants, Pages 499-506, L. CHEDID, S. KOTANI
Summary and Conclusions of the Therapy and Communication Session: Lymphokine and Transfer Factor, Pages 507-511, Ben Papermaster, Dudley Dumonde
Author Index, Pages 513-514
Subject Index, Pages 515-517